Citations

Citations to this article as recorded by  

• Comparative short-term efficacy of upadacitinib versus tofacitinib for ulcerative colitis: a 24-week real-world study in Japan
  Akiko Tamura, Hiromichi Shimizu, Toshimitsu Fujii, Ami Kawamoto, Ryo Morikawa, Shuji Hibiya, Kento Takenaka, Masakazu Nagahori, Kazuo Ohtsuka, Ryuichi Okamoto
  Intestinal Research.2026; 24(1): 95.     CrossRef
• Tofacitinib safety in inflammatory bowel disease: a disproportionality analysis of the FDA adverse event reporting system
  Suqi Zeng, Sihan Zhang, Jianxuan Sun, Junjie Chen
  Naunyn-Schmiedeberg's Archives of Pharmacology.2026; 399(9): 14029.     CrossRef
• Inflammatory bowel disease therapeutics: a bibliometric analysis of tofacitinib research in ulcerative colitis
  Jianping Zhou, Yuting Xi, Yaping Zhang, Rui Zhang, Hao Fu, Ce Zhou
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Association between inflammatory bowel disease, current therapies, and cardiovascular events: a review and meta-analysis of data from 2.2 million individuals
  David-Raj Thomas, Gavin Huangfu, Fiona Yeaman, Sara Sukudom, Nick S R Lan, Girish Dwivedi, Lena Thin
  Journal of Crohn's and Colitis.2025;[Epub]     CrossRef
• Toward Precision Medicine: Molecular Biomarkers of Response to Tofacitinib in Inflammatory Bowel Disease
  Anja Bizjak, Boris Gole, Gregor Jezernik, Uroš Potočnik, Mario Gorenjak
  Genes.2025; 16(8): 908.     CrossRef
• Histological healing induced by tofacitinib in ulcerative colitis: A multicentre study
  Sophie Vieujean, David Laharie, Anthony Buisson, Xavier Roblin, Mathurin Fumery, Stephane Nancey, Pauline Wils, Romain Altwegg, Laurence Seidel, Bénédicte Caron, Laurent Peyrin-Biroulet
  Digestive and Liver Disease.2024; 56(4): 613.     CrossRef
• Continued JAK inhibitor treatment on the risk of recurrent herpes zoster reactivation in patients with immune-mediated inflammatory diseases: A nationwide population-based study in South Korea
  Young-Eun Kim, Ye-Jee Kim, Dae Hyun Jeong, Seonok Kim, Min Jee Kim, Hyeon Hwa Kim, Kyung-Wook Jo, Sang Hyoung Park, Seokchan Hong
  Seminars in Arthritis and Rheumatism.2024; 65: 152362.     CrossRef
• Preventing and managing cardiovascular events in patients with inflammatory bowel diseases treated with small-molecule drugs, an international Delphi consensus
  Pablo A. Olivera, Axel Dignass, Marla C. Dubinsky, Giovanni Peretto, Paulo G. Kotze, Iris Dotan, Taku Kobayashi, Subrata Ghosh, Fernando Magro, Jose Rocha Faria-Neto, Britta Siegmund, Silvio Danese, Laurent Peyrin-Biroulet
  Digestive and Liver Disease.2024; 56(8): 1270.     CrossRef
• Long-term efficacy and safety of tofacitinib in patients with ulcerative colitis: 3-year results from a real-world study
  Hiromichi Shimizu, Yuko Aonuma, Shuji Hibiya, Ami Kawamoto, Kento Takenaka, Toshimitsu Fujii, Eiko Saito, Masakazu Nagahori, Kazuo Ohtsuka, Ryuichi Okamoto
  Intestinal Research.2024; 22(3): 369.     CrossRef
• Safety and effectiveness of tofacitinib in Korean adult patients with ulcerative colitis: post-marketing surveillance study
  Hyuk Yoon, Byong Duk Ye, Sang-Bum Kang, Kang-Moon Lee, Chang Hwan Choi, Joo-young Jo, Juwon Woo, Jae Hee Cheon
  BMC Gastroenterology.2024;[Epub]     CrossRef
• Effectiveness of tofacitinib in patients with ulcerative colitis: an updated systematic review and meta-analysis of real-world studies
  Chien-Hung Lin, Wen-Sheng Liu, Chuan Wan, Hsin-Hui Wang
  BMJ Open Gastroenterology.2024; 11(1): e001347.     CrossRef
• Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
  María Chaparro, Diana Acosta, Cristina Rodríguez, Francisco Mesonero, Miren Vicuña, Manuel Barreiro-de Acosta, Agnès Fernández-Clotet, Álvaro Hernández Martínez, Maite Arroyo, Isabel Vera, Alexandra Ruiz-Cerulla, Beatriz Sicilia, M. José Cabello Tapia, Ca
  American Journal of Gastroenterology.2023; 118(7): 1237.     CrossRef
• Real-life effectiveness and safety of tofacitinib treatment in patients with ulcerative colitis: a KASID multicenter cohort study
  Seung Hwan Shin, Kyunghwan Oh, Sung Noh Hong, Jungbok Lee, Shin Ju Oh, Eun Soo Kim, Soo-Young Na, Sang-Bum Kang, Seong-Joon Koh, Ki Bae Bang, Sung-Ae Jung, Sung Hoon Jung, Kyeong Ok Kim, Sang Hyoung Park, Suk-Kyun Yang, Chang Hwan Choi, Byong Duk Ye
  Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
• Review article: Risk of cardiovascular events in patients with inflammatory bowel disease receiving small molecule drugs
  Pablo A. Olivera, Juan S. Lasa, Giovanni Peretto, Stephane Zuily, Silvio Danese, Laurent Peyrin‐Biroulet
  Alimentary Pharmacology & Therapeutics.2023; 57(11): 1231.     CrossRef
• Positioning of tofacitinib in treatment of ulcerative colitis: a global perspective
  Shubhra Mishra, Anuraag Jena, Rinkalben Kakadiya, Vishal Sharma, Vineet Ahuja
  Expert Review of Gastroenterology & Hepatology.2022; 16(8): 737.     CrossRef
• Oral beclomethasone dipropionate as an add-on therapy and response prediction in Korean patients with ulcerative colitis
  Kyuwon Kim, Hee Seung Hong, Kyunghwan Oh, Jae Yong Lee, Seung Wook Hong, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye, Sang Hyoung Park
  The Korean Journal of Internal Medicine.2022; 37(6): 1140.     CrossRef
• Review article: guide to tofacitinib dosing in patients with ulcerative colitis
  Peter M. Irving, Yvette Leung, Marla C. Dubinsky
  Alimentary Pharmacology & Therapeutics.2022; 56(7): 1131.     CrossRef
• Management of inflammatory bowel disease beyond tumor necrosis factor inhibitors: novel biologics and small-molecule drugs
  Soo-Young Na, You Sun Kim
  The Korean Journal of Internal Medicine.2022; 37(5): 906.     CrossRef
• Effectiveness and Safety of Tofacitinib for Ulcerative Colitis
  Vikas Taneja, Mohammed El-Dallal, Zadid Haq, Kartikeya Tripathi, Hannah K. Systrom, Linda F. Wang, Hyder Said, Paul A. Bain, Youlian Zhou, Joseph D. Feuerstein
  Journal of Clinical Gastroenterology.2022; 56(10): e323.     CrossRef
• Real-world experience with tofacitinib in ulcerative colitis: a systematic review and meta-analysis
  Laura A. Lucaciu, Nathan Constantine-Cooke, Nikolas Plevris, Spyros Siakavellas, Lauranne A.A.P. Derikx, Gareth-Rhys Jones, Charles W. Lees
  Therapeutic Advances in Gastroenterology.2021;[Epub]     CrossRef